Protein in Urine Indicator of Kidney Disease
Written by WTJ on February 13, 2009 – 10:32 pm -
Think you are healthy? Don’t forget to check your urinary protein levels before it is too late.
Researcher Ronald T. Gansevoort from University Medical Center Groningen, Netherlands, and colleagues found that high urinary proteins levels people had higher risk of suffering chronic kidney disease (CDK). The study collected urine samples from 40,000 healthy individuals. The urinary albumin levels were checked. The researcher followed these individuals and noted those who had kidney function failure over nine years. It was found that patients with increasing urinary protein levels had higher chance of losing kidney function and need dialysis or kidney transplant. The study excluded the screen for albuminuria in the population with hypertension, diabetes, cardiovascular disease history, older age to reduce the sensitivity of the test.
The study was published online in Journal of the American Society of Nephrology. Other authors are Marije van der Velde, Nynke Halbesma, Frank T. de Charro, Stephan J.L. Bakker, Dick de Zeeuw, and Paul E. de Jong.
This is a simple and low-cost urine screening to identify the potential CKD. Another way (but not effective) to check your urine protein is by looking at the amount of urine bubbles. It is said the more urine bubbles you had, the higher the protein levels. However it is recommended to check with specific tester or clinical urine tests.
Related posts:
Tags: Albumin, albuminuria, chronic kidney disease, Frank T. de Charro, kidney, Kidney disease, Marije van der Velde, Nynke Halbesma, renal replacement therapy, Ronald T. Gansevoort, Stephan J.L. Bakker, University Medical Center Groningen, urinary albumin, urine, Urology | 2 Comments »




December 10th, 2009 at 10:47 pm
An FDA advisory panel just recommended yesterday that the warning label for Covidien’s Optimark and GE’s Omnisca—drugs in the family of medications known as gadolinium-based contrast agents (DBCAs)—be updated to restrict their use in patients with severe kidney disease because of the potential for an increased risk of nephrogenic systemic fibrosis (NSF). NSF causes thickening of the skin and organs. GBCAs carry a strong “black box” warning. This site has good information on this issue: http://www.gadolinium-mri.com/index.html
December 17th, 2009 at 9:44 pm
A recommendation has been made to increase the warning for Covidien’s Optimark and GE’s Omnisca—gadolinium-based contrast agents (DBCAs)— because of the potential for an increased risk of nephrogenic systemic fibrosis (NSF). This site has good information on this issue: http://www.gadolinium-mri.com/index.html